Try
BIO-TECHNE Corp
TECHUnited States
73 filed reports · 633 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
73 reports · Dec 2006 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 72 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 57 | 7,804 | Dec 2006 to Mar 2026 |
| Annual · 10-KSEC EDGAR | 15 | 7,462 | Jun 2011 to Jun 2026 |
| Annual · 10-K/ASEC EDGAR | 1 | 412 | Jun 2019 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 | 10-K | Jun 30, 2026 | Aug 24, 2026 | 1,139 | Open |
| FY2026 Q3 | 10-Q | Mar 31, 2026 | May 6, 2026 | 336 | Open |
| FY2026 Q2 | 10-Q | Dec 31, 2025 | Feb 4, 2026 | 260 | Open |
| FY2026 Q1 | 10-Q | Sep 30, 2025 | Nov 5, 2025 | 270 | Open |
| FY2025 | 10-K | Jun 30, 2025 | Aug 22, 2025 | 530 | Open |
| FY2025 Q3 | 10-Q | Mar 31, 2025 | May 8, 2025 | 225 | Open |
| FY2025 Q2 | 10-Q | Dec 31, 2024 | Feb 6, 2025 | 169 | Open |
| FY2025 Q1 | 10-Q | Sep 30, 2024 | Nov 5, 2024 | 184 | Open |
| FY2024 | 10-K | Jun 30, 2024 | Aug 22, 2024 | 541 | Open |
| FY2024 Q3 | 10-Q | Mar 31, 2024 | May 6, 2024 | 240 | Open |
| FY2024 Q2 | 10-Q | Dec 31, 2023 | Feb 7, 2024 | 185 | Open |
| FY2024 Q1 | 10-Q | Sep 30, 2023 | Nov 7, 2023 | 185 | Open |
Financial data
633 concepts · 15,678 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial596 concepts · 14,043 facts · Jun 2009 to Jun 2026
- Cash and cash equivalents at carrying value87 · Jun 2009 to Jun 2026
- Cost of goods and services sold (US GAAP)86 · Jun 2009 to Jun 2026
- Depreciation depletion and amortization86 · Jun 2009 to Jun 2026
- Gross profit (US GAAP)86 · Jun 2009 to Jun 2026
- Income tax expense benefit86 · Jun 2009 to Jun 2026
- Increase decrease in accounts and other receivables86 · Jun 2009 to Jun 2026
- Increase decrease in accounts payable and accrued liabilities86 · Jun 2009 to Jun 2026
- Increase decrease in employee related liabilities86 · Jun 2009 to Jun 2026
- Increase decrease in inventories86 · Jun 2009 to Jun 2026
- Investment income net86 · Jun 2009 to Jun 2026
- Nonoperating income expense86 · Jun 2009 to Jun 2026
- Operating expenses (US GAAP)86 · Jun 2009 to Jun 2026
- Operating income loss86 · Jun 2009 to Jun 2026
- Payments of dividends common stock86 · Jun 2009 to Jun 2026
- Payments to acquire property plant and equipment86 · Jun 2009 to Jun 2026
- Proceeds from stock options exercised86 · Jun 2009 to Jun 2026
- Research and development expense excluding acquired in process cost86 · Jun 2009 to Jun 2026
- Revenue86 · Jun 2009 to Jun 2026
- Selling general and administrative expense86 · Jun 2009 to Jun 2026
- Accumulated other comprehensive income loss net of tax84 · Jun 2009 to Jun 2026
- Assets84 · Jun 2009 to Jun 2026
- Finite lived intangible assets net84 · Jun 2009 to Jun 2026
- Goodwill (US GAAP)84 · Jun 2009 to Jun 2026
- Net income loss84 · Jun 2009 to Mar 2026
Segment30 concepts · 981 facts · Jun 2009 to Jun 2026
- Revenue252 · Jun 2009 to Jun 2026
- Operating income loss172 · Jun 2013 to Jun 2026
- Goodwill116 · Jun 2014 to Mar 2026
- Goodwill foreign currency translation gain loss98 · Jun 2016 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest57 · Jun 2010 to Jun 2014
- Goodwill acquired during period44 · Jun 2016 to Jun 2024
- Depreciation depletion and amortization30 · Jun 2009 to Jun 2016
- Payments to acquire property plant and equipment28 · Jun 2009 to Jun 2016
- Cost of goods and services sold (US GAAP)24 · Jun 2023 to Jun 2026
- Research and development expense excluding acquired in process cost24 · Jun 2023 to Jun 2026
- Selling general and administrative expense24 · Jun 2023 to Jun 2026
- Total Assets23 · Jun 2010 to Jun 2016
- Earnings before income taxes12 · Jun 2009 to Jun 2011
- Pretax Income11 · Sep 2010 to Mar 2013
- Cost of Sales9 · Mar 2024 to Jun 2024
- QT Holdings Corporation9 · Jun 2022 to Jun 2024
- Protein Sciences7 · Jun 2020 to Jun 2025
- Restructuring charges7 · Sep 2021 to Jun 2024
- Revenue (including assessed tax)6 · Mar 2017 to Jun 2017
- Goodwill purchase accounting adjustments5 · Mar 2017 to Jun 2023
- Goodwill impairment loss net of tax4 · Dec 2021 to Jun 2022
- Capital Expenditures3 · Jun 2010 to Jun 2012
- Depreciation & Amortization3 · Jun 2010 to Jun 2012
- Operating Segments3 · Sep 2024 to Sep 2025
Geography3 concepts · 368 facts · Jun 2009 to Jun 2026
- Revenue336 · Jun 2009 to Jun 2026
- Intangible Assets (excluding Goodwill)26 · Jun 2017 to Jun 2025
- Income tax expense (benefit), discrete tax items6 · Dec 2021 to Mar 2024
Product1 concepts · 230 facts · Jun 2017 to Jun 2026
- Revenue230 · Jun 2017 to Jun 2026
Guidance3 concepts · 56 facts · Feb 2007 to Aug 2015
- Effective Tax Rate Guidance32 · Nov 2008 to Aug 2013
- Capital Expenditures Guidance22 · Feb 2007 to Aug 2015
- Revenue Growth Guidance2 · Feb 2008
Segments
1,579 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement business segments29 members · 981 facts
- Protein Sciences219 · Jun 2017 to Jun 2026
- Diagnostics And Spatial Biology209 · Jun 2017 to Jun 2026
- Biotechnology117 · Jun 2009 to Jun 2018
- Protein Platforms66 · Jun 2013 to Jun 2018
- Clinical Controls52 · Jun 2011 to Jun 2016
- Diagnostics and spatial biology40 · Jun 2018 to Mar 2026
- Protein sciences40 · Jun 2018 to Mar 2026
- Hematology38 · Jun 2009 to Mar 2013
- Diagnostics37 · Jun 2015 to Jun 2018
- Reportable Segments23 · Jun 2009 to Mar 2013
- Unallocated Amount To23 · Jun 2009 to Mar 2013
- Biotechnology21 · Jun 2010 to Jun 2018
- Reportable segments20 · Jun 2010 to Mar 2013
- Protein platforms15 · Jun 2015 to Jun 2018
- Diagnostics12 · Jun 2016 to Jun 2018
- Other Revenues From Business Held For Sale8 · Mar 2024 to Mar 2025
- Clinical controls8 · Jun 2012 to Jun 2016
- All Other Segments5 · Jun 2024 to Sep 2025
- CN3 · Jun 2010 to Jun 2012
- Corporate3 · Mar 2024 to Jun 2024
- Europe3 · Jun 2010 to Jun 2012
- Other Asia3 · Jun 2010 to Jun 2012
- Rest Of World3 · Jun 2010 to Jun 2012
- Hematology3 · Jun 2010 to Jun 2012
- US3 · Jun 2010 to Jun 2012
- Unallocated amount to segment3 · Jun 2010 to Jun 2012
- R And D Europe2 · Jun 2010
- Cn1 · Jun 2015
- Rest of world1 · Jun 2015
Statement geographicalsrt:StatementGeographicalAxis10 members · 313 facts
- CN53 · Jun 2016 to Jun 2026
- APAC Excluding Greater China47 · Jun 2016 to Jun 2026
- EMEA Excluding UK47 · Jun 2016 to Jun 2026
- Rest Of World47 · Jun 2016 to Jun 2026
- US47 · Jun 2016 to Jun 2026
- GB46 · Jun 2016 to Jun 2026
- United states and canada9 · Jun 2017 to Jun 2025
- Europe8 · Jun 2017 to Jun 2025
- Asia7 · Jun 2018 to Jun 2024
- Cn2 · Jun 2017 to Jun 2018
Product or service5 members · 230 facts
- Consumables46 · Jun 2017 to Jun 2026
- Instruments46 · Jun 2017 to Jun 2026
- Product And Services46 · Jun 2017 to Jun 2026
- Royalty46 · Jun 2017 to Jun 2026
- Service46 · Jun 2017 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis10 members · 55 facts
- CN9 · Jun 2009 to Jun 2017
- US9 · Jun 2009 to Jun 2017
- Europe8 · Jun 2009 to Jun 2015
- Rest Of World7 · Jun 2011 to Jun 2017
- Other Asia6 · Jun 2011 to Jun 2016
- GB4 · Jun 2014 to Jun 2017
- APAC Excluding Greater China3 · Jun 2015 to Jun 2017
- EMEA Excluding UK3 · Jun 2015 to Jun 2017
- Europe Other Than UK3 · Jun 2014 to Jun 2016
- Other Areas3 · Jun 2009 to Jun 2011
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary72 claims from 7 reports · Dec 2024 to Jun 2026
- Management discussion (MD&A) commentary131 claims from 8 reports · Sep 2024 to Jun 2026
- Risk-factor changes9 claims from 1 reports · Jun 2026
- Risk factors59 risks from 2 annual reports · 2025 to 2026
Earnings calls
1 calls · May 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q3May 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.